ANACOR PHARMACEUTICALS INC Inactive Instrument
Anacor Pharmaceuticals Inc Stock
Equities
US0324201013
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
| 2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
| Chief Tech/Sci/R&D Officer | 77 | 04-01-31 | |
| Director/Board Member | - | 16-06-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Bryan Supran
BRD | Director/Board Member | - | 16-06-23 |
| Director/Board Member | - | 16-06-23 |
| 1st Jan change | Capi. | |
|---|---|---|
| +21.74% | 46.81B | |
| -0.97% | 41.37B | |
| +47.07% | 41.29B | |
| -3.52% | 28.87B | |
| +11.12% | 26.06B | |
| -19.37% | 19.13B | |
| +31.18% | 12.39B | |
| -0.04% | 12.08B | |
| +0.39% | 11.96B |
- Stock Market
- Equities
- Stock